André J. McDonald

André J. McDonald

Auto-generated profile, based on publicly available information

André J. McDonald

Peter Boris Centre for Addictions Research St. Joseph's Healthcare Hamilton Hamilton Ontario Canada

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 May 2024 in Psychological Medicine
Verified
Journal Article
Open access
PDF file
AMAndré J. McDonald
André J. McDonald
PKPaul Kurdyak
Paul Kurdyak
JRJürgen Rehm
Jürgen Rehm
MRMichael Roerecke
Michael Roerecke
SBSusan J. Bondy
Susan J. Bondy
Background: Epidemiologic research suggests that youth cannabis use is associated with psychotic disorders. However, current evidence is based heavily on 20th-century data when cannabis was substantially less potent than today.Methods: We linked population-based survey data from 2009 to 2012 with records of health services covered under universal healthcare in Ontario, Canada, up to 2018. The cohort included respondents aged 12–24 years at baseline with no prior psychotic disorder (N = 11 363). The primary outcome was days to first hospitalization, ED visit, or outpatient visit related to a psychotic disorder according to validated diagnostic codes. Due to non-proportional hazards, we estimated age-specific hazard ratios during adolescence (12–19 years) and young adulthood (20–33 years). Sensitivity analyses explored alternative model conditions including restricting the outcome to hospitalizations and ED visits to increase specificity.Results: Compared to no cannabis use, cannabis use was significantly associated with psychotic disorders during adolescence (aHR = 11.2; 95% CI 4.6–27.3), but not during young adulthood (aHR = 1.3; 95% CI 0.6–2.6). When we restricted the outcome to hospitalizations and ED visits only, the strength of association increased markedly during adolescence (aHR = 26.7; 95% CI 7.7–92.8) but did not change meaningfully during young adulthood (aHR = 1.8; 95% CI 0.6–5.4).Conclusions: This study provides new evidence of a strong but age-dependent association between cannabis use and risk of psychotic disorder, consistent with the neurodevelopmental theory that adolescence is a vulnerable time to use cannabis. The strength of association during adolescence was notably greater than in previous studies, possibly reflecting the recent rise in cannabis potency.

1 December 2021 in Preventive Medicine
Verified
Journal Article
Closed access
AMAndré J. McDonald
André J. McDonald
HHHayley A. Hamilton
Hayley A. Hamilton
CWChristine M. Wickens
Christine M. Wickens
TWTara Marie Watson
Tara Marie Watson
TETara Elton-Marshall
Tara Elton-Marshall
RMRobert E. Mann
Robert E. Mann

13 February 2022 in Psychiatry Research
Verified
Journal Article
Closed access
AMAndré J. McDonald
André J. McDonald
Christine M. WickensChristine M. Wickens
Christine M. Wickens
SBSusan J Bondy
Susan J Bondy
TETara Elton-Marshall
Tara Elton-Marshall
SWSamantha Wells
Samantha Wells
HHHayley A. Hamilton
Hayley A. Hamilton

21 April 2025 in International Journal of Drug Policy
Verified
Journal Article
Open access
ADAmanda Doggett
Amanda Doggett
KBKyla L. Belisario
Kyla L. Belisario
AMAndré J. McDonald
André J. McDonald
JJJane De Jesus
Jane De Jesus
EVEmily Vandehei
Emily Vandehei
JMJames MacKillop
James MacKillop
Social acceptability and perceived risks/benefits are key attitudinal factors that influence substance use, and a major concern about cannabis legalization is an increase in more favourable attitudes ultimately leading to greater cannabis misuse. This study investigated perceptions of cannabis acceptability and risks/benefits over the 5 years following legalization in Canada, the first G7 nation to have legalized cannabis nationally, in a longitudinal observational cohort of community adults. Participants (60 % female, median age = 29, 48% reporting cannabis use pre-legalization) were non-clinical adults from the general community who were assessed up to 11 times from September 2018 to October 2023 (mean waves = 9.9). Overall temporal attitudinal changes and whether changes were moderated by pre-legalization cannabis use status were examined. Significant increases over time were present for social acceptability of any recreational cannabis use (OR [95% CI]: 1.06 [1.05, 1.07]) and trying cannabis (1.02 [1.01, 1.03]), while acceptability of medical cannabis use decreased (0.95 [0.94, 0.96]). Meanwhile, regular cannabis use was perceived as riskier (0.97 [0.96, 0.98]) and addiction potential was perceived as greater (0.94 [0.93, 0.95]) over time. Perceived health-related benefits of cannabis were significantly less likely to be endorsed over time, while there were significant increases in perceived risks, including exacerbating stress, anxiety, and depression; exacerbating existing medical conditions; and disrupting sleep. Moderator analyses found participants not using cannabis pre-legalization showed significantly steeper increases towards greater social acceptability of occasional and regular use, and less steep increases in endorsement of cannabis-related risks. Shifting social acceptability of cannabis post-legalization in Canada is paralleled by increases in perceived health-related risks and decreases in perceived benefits. Continued surveillance of attitudinal changes following legalization in Canada is warranted to inform the impacts in the largest national legal cannabis jurisdiction as well as other jurisdictions considering regulatory reform.

30 June 2019 in Addiction
Verified
Journal Article
Open access
PDF file
AMAndré J. McDonald
André J. McDonald
MRMichael Roerecke
Michael Roerecke
RMRobert E. Mann
Robert E. Mann

1 April 2025 in JAMA Network Open
Verified
Journal Article
Open access
AMAndré J. McDonald
André J. McDonald
ADAmanda Doggett
Amanda Doggett
KBKyla Belisario
Kyla Belisario
JGJessica Gillard
Jessica Gillard
JJJane De Jesus
Jane De Jesus
JMJames MacKillop
James MacKillop
Importance: An increasing number of jurisdictions have legalized recreational cannabis for adults, but most evaluations have used repeated cross-sectional designs, preventing examination of within-person and subgroup trajectories across legalization.Objective: To examine changes in cannabis use and misuse in the 5 years following legalization in Canada both overall and by prelegalization cannabis use frequency using a longitudinal design.Design, Setting, and Participants: This prospective cohort study included data from community-dwelling adults who participated in up to 11 biannual assessments from September 2018 to October 2023 in Ontario, Canada. Data were analyzed from November 2023 to January 2024.Exposure: Five years of recreational cannabis legalization (baseline wave was immediately prior to legalization).Main Outcome and Measures: Primary outcomes were cannabis use frequency and cannabis misuse, assessed using Cannabis Use Disorder Identification Test – Revised (CUDIT-R) score. Prelegalization cannabis use frequency, age, and sex were examined as moderators. Secondary outcomes included changes in cannabis product preferences over time.Results: The final cohort included 1428 community-dwelling adults aged 18 to 65 years (859 [60.2%] female; mean [SD] age, 34.5 [13.9] years). Mean retention was 90% across all waves. Linear mixed-effects modeling found a significant increase in cannabis use frequency, such that the mean proportion of days using cannabis increased by 0.35% (95% CI, 0.19% to 0.51%) per year (P < .001) in the overall sample (1.75% over 5 years). In contrast, CUDIT-R scores (on scale of 0 to 32) decreased significantly overall (β = −0.08 [95% CI, −0.10 to −0.06] per year; −0.4 over 5 years; P < .001), most notably with the onset of the COVID-19 pandemic. Interaction analyses indicated that prelegalization cannabis use frequency significantly moderated changes for both outcomes (P < .001). Specifically, cannabis use and misuse decreased among prelegalization frequent consumers and modestly increased among occasional users and nonusers. Cannabis product preferences shifted away from dried flower, hashish, concentrates, oil, tinctures, and topicals to edibles, liquids, and vape pens.Conclusions and Relevance: In this prospective cohort study of community-dwelling adults in Canada, cannabis use frequency increased modestly in the 5 years following legalization, while cannabis misuse decreased modestly. These changes were substantially moderated by prelegalization cannabis use, with more frequent consumers of cannabis before legalization exhibiting the largest decreases in both outcomes. Although longer-term surveillance is required, these results suggest Canadian recreational cannabis legalization was associated with modest negative and positive consequences among adults.